A new therapeutic avenue in Clostridioides difficile Infection
Akshita Kumar Clostridioides difficile is an anaerobic Gram-positive bacteria that is capable of forming spores. Clostridioides difficile infection (CDI) is the most common reason behind hospital-acquired gastrointestinal infections and mortality in industrialised nations, with an estimated 223,900 infections, 12,800 deaths, and a $1 billion healthcare cost in 2017. In recent years, there has also been a rise in the number of community-associated […]